Exon-skipping drug prevents muscle wasting, maintains muscle function in dystrophin deficient mice

Posted By News On October 20, 2009 - 2:30pm
Exon-skipping drug prevents muscle wasting, maintains muscle function in dystrophin deficient mice

This is a supplementary video to the Molecular Therapy publication "Prevention of Dystrophic Pathology in Severely Affected Dystrophin/Utrophin-deficient Mice by Morpholino-oligomer-mediated Exon-skipping" showing visual evidence of mouse with pronounced curving of the spine and dramatically reduced mobility as a result of deficiency of both dystrophin and utrophin proteins.

(Photo Credit: University of Oxford)

This is a supplementary video to the Molecular Therapy publication "Prevention of Dystrophic Pathology in Severely Affected Dystrophin/Utrophin-deficient Mice by Morpholino-oligomer-mediated Exon-skipping"illustrating the impact of PPMO treatment on dKO mouse.

(Photo Credit: University of Oxford)

Post new comment

The content of this field is kept private and will not be shown publicly.
  • Allowed HTML tags: <em> <strong> <cite><p><br><i><b><center><ul><li><div><html5:figure><html5:figcaption>
  • Lines and paragraphs break automatically.

More information about formatting options

CAPTCHA
Sorry, we know you're not a spambot, but they're out there